Do I need an in-person exam for Strattera in New York?

Understanding Telehealth ADHD Medication Options

Seeking treatment for ADHD via telehealth has become increasingly common, with many patients wondering which medications can be legally prescribed through virtual care. If you’re specifically looking for non-stimulant options like Strattera (atomoxetine), you’re in luck – these medications face fewer regulatory restrictions than stimulants like Adderall or Ritalin.

This comprehensive guide explains the current telehealth prescribing landscape for Strattera across different states, clarifying what’s possible under today’s regulations and what to expect during the process.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

What is Strattera and Why Consider It?

Strattera (atomoxetine) is an FDA-approved medication for treating ADHD in children, adolescents, and adults. Unlike stimulant medications, Strattera is not a controlled substance, which means:

• It doesn’t carry the same risk of dependence or abuse as stimulants
• It’s subject to fewer prescribing restrictions
• It can typically be prescribed with refills (up to 90-day supply in many cases)
• It’s generally easier to obtain via telehealth in all 50 states

Strattera works differently than stimulants – instead of increasing dopamine, it’s a norepinephrine reuptake inhibitor that helps improve focus and reduce impulsivity without the stimulating effects. While it may take longer to show benefits (usually 2-4 weeks versus the immediate effects of stimulants), many patients find it effective with fewer concerns about misuse potential.

Federal Regulations: Good News for Non-Stimulant ADHD Meds

At the federal level, there are no special restrictions on prescribing Strattera via telehealth. This is because the Ryan Haight Act (which normally requires an in-person examination before prescribing controlled substances online) doesn’t apply to non-controlled medications like Strattera.

Even for controlled ADHD medications, the Drug Enforcement Administration (DEA) has extended COVID-era telehealth flexibilities through December 31, 2025, allowing virtual prescribing without prior in-person visits. However, non-stimulants like Strattera never needed this special exemption in the first place – they’ve always been legally prescribable via telehealth.

State-by-State Telehealth Rules for Strattera

While federal law places no restrictions on telehealth prescribing of Strattera, state laws can still impact your experience. Here’s what to know about key states:

California

• Telehealth prescribing of Strattera: Fully permitted
• In-person requirement: None for non-controlled medications
• Provider types: MDs, DOs, NPs (with independent practice), and PAs (with supervision) can all prescribe
• Special considerations: California has embraced telehealth, with no state-level barriers for non-stimulant ADHD medications

New York

• Telehealth prescribing of Strattera: Fully permitted
• In-person requirement: None for non-controlled medications (NY does require in-person visits for controlled substances as of 2025)
• Provider types: MDs, DOs, and NPs with 3,600+ hours experience can prescribe independently; PAs require supervision
• Special considerations: While NY implemented stricter rules for controlled substances in 2025, these don’t affect Strattera prescriptions

Florida

• Telehealth prescribing of Strattera: Fully permitted
• In-person requirement: None for non-controlled medications
• Provider types: MDs, DOs, and supervised NPs/PAs can prescribe
• Special considerations: Florida requires audio-visual telehealth (no phone-only) for all prescribing

Texas

• Telehealth prescribing of Strattera: Fully permitted
• In-person requirement: None for non-controlled medications
• Provider types: MDs, DOs, and supervised NPs/PAs can prescribe non-stimulants
• Special considerations: Texas is generally telehealth-friendly for mental health conditions

Alabama

• Telehealth prescribing of Strattera: Permitted, with follow-up requirements
• In-person requirement: For ongoing telehealth care, Alabama typically requires an in-person visit within 12 months, but there’s an exemption for mental health services (which ADHD falls under)
• Provider types: MDs, DOs, and NPs/PAs with proper supervision can prescribe
• Special considerations: Alabama has some of the stricter telehealth rules, but non-stimulant ADHD medications remain accessible

Other States

Most remaining states have similarly permissive policies for non-stimulant ADHD medications via telehealth. Even in states with telehealth restrictions, these typically target controlled substances rather than medications like Strattera.

What to Expect During a Telehealth ADHD Evaluation

A legitimate telehealth evaluation for ADHD and potential Strattera prescription typically includes:

1. Comprehensive assessment: Expect a detailed interview about your symptoms, medical history, family history, and any previous treatments. This is not a quick 5-minute chat.

2. Standard screening tools: Many providers use standardized ADHD questionnaires to assess symptom severity.

3. Discussion of treatment options: Your provider should discuss both medication and non-medication options, including the differences between stimulants and non-stimulants.

4. Medical clearance: Before prescribing Strattera, the provider will check for contraindications like narrow-angle glaucoma, certain heart conditions, or recent use of MAOI medications.

5. Ongoing monitoring: Expect follow-up appointments to assess medication effectiveness and adjust dosage if needed. Strattera typically takes 4-6 weeks to reach full effectiveness.

The Strattera Advantage in Telehealth

There are several benefits to choosing Strattera through telehealth:

• Fewer regulatory hurdles: Without controlled substance restrictions, the prescription process is more straightforward
• Longer prescription duration: Often available in 90-day supplies with refills
• Reduced stigma: No risk of being labeled as seeking controlled substances
• Consistent availability: Less affected by pharmacy shortages that often impact stimulants
• Fewer telehealth restrictions: Available in all 50 states via telehealth

At Klarity Health, we’ve found many patients appreciate the simplicity of non-stimulant options like Strattera in their telehealth treatment journey. Our providers can help determine if Strattera might be right for your specific ADHD symptoms and circumstances.

Common Misconceptions About Telehealth ADHD Treatment

Myth: ‘Telehealth ADHD prescriptions are automatic’

Reality: Legitimate providers perform thorough evaluations before any prescription. If a service seems too quick or ‘guaranteed,’ that’s a red flag.

Myth: ‘Non-stimulants aren’t effective’

Reality: While stimulants work for many people, Strattera can be highly effective for others, especially those with concerns about stimulant side effects or dependence. It’s a clinically-proven treatment that works differently but effectively for many patients.

Myth: ‘Telehealth prescriptions won’t be filled by pharmacies’

Reality: Pharmacies routinely fill telehealth prescriptions, including for Strattera. Electronic prescriptions don’t distinguish between telehealth and in-person visits.

Tips for Success with Telehealth ADHD Treatment

1. Choose reputable providers: Look for platforms with licensed clinicians and clear policies. At Klarity Health, all our providers are board-certified and licensed in your state, with experience in ADHD diagnosis and treatment.

2. Be honest and thorough: The quality of your care depends on the information you provide. Be upfront about your symptoms, medical history, and previous treatments.

3. Follow treatment plans and attend follow-ups: Strattera often takes several weeks to reach full effectiveness, so consistent use and follow-up appointments are essential.

4. Know your insurance coverage: While Strattera is typically covered by insurance plans, coverage varies. Klarity Health works with most major insurance providers and also offers transparent cash pricing for those without coverage.

5. Consider a comprehensive approach: Medication works best when combined with other strategies. Ask about behavioral techniques, organizational skills, and therapy options that can complement your medication.

Looking Ahead: Telehealth Regulations in 2026

The regulatory landscape for telehealth continues to evolve. While non-stimulant medications like Strattera should remain accessible via telehealth regardless of potential changes, the DEA’s current flexibilities for controlled substances are set to expire on December 31, 2025.

Patients currently using stimulants via telehealth should stay informed about potential regulatory changes

Source:

• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20Drug%20Enforcement%20Administration%20,Federal%20Register%20on%20Friday%20night
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=visit,examination%20through%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20%E2%80%9CThird%20Temporary%20Extension%20of,14
• https://www.medicalnewstoday.com/articles/drugs-is-strattera-a-controlled-substance#:~:text=Strattera%20,such%20as%20mental%20health%20issues
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=The%20,False%20Hope
• https://www.techtarget.com/virtualhealthcare/news/366616019/Telehealth-prescribing-flexibility-extended-through-2025#:~:text=Image%20filo%2FDigitalVision%20Vectors%20via%20G,The
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Extend%20natlawreview,before%20issuing%20a%20dangerous%20drug
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=,specifically%20for%20chronic%20pain%20treatment